Latest Blog Posts Tagged "Parkinson's Progression Markers Initiative"
September 13, 2018
Deputy CEO, Sohini Chowdhury, talked to Roche for an article discussing PPMI and the importance of sharing data.
August 03, 2018
A podcast from the National Gaucher Foundation covers the genetic connection between Parkinson's and Gaucher diseases and new treatments in the works.
July 31, 2018
The European Medicines Agency has, for the first time, supported a brain scan to help choose trial participants. It could speed drug trials and improve their chances of success.
May 09, 2018
The Michael J. Fox Foundation and Verily are outfitting more than 800 study participants with wearable devices to better understand and track disease to add a new dimension of health data to the PPMI.
March 28, 2018
Findings from two studies supported by The Michael J. Fox Foundation report how Parkinson's motor symptoms progress in distinct patient populations.
March 22, 2018
In the latest "Ask the MD" video, Dr. Dolhun talks about how doctors diagnose Parkinson's and how a tool called a biomarker may help.
March 20, 2018
The Lancet Neurology calls the AMP PD program the 'most ambitious initiative so far to find a cure for Parkinson's.'
January 30, 2018
The Michael J. Fox Foundation, National Institutes of Health and five industry partners unite to find molecular difference in Parkinson's.
October 13, 2017
Analysis from the MJFF-led PPMI points to potential use of these biomarkers for testing drug engagement but likely not for tracking short-term progression.
October 03, 2017
David Levine, MD, MPH, shares his experiences as a participant in the Levodopa Response Trial and thoughts on PD scientists using his data to advance research.